CAPTRUST Financial Advisors
SGYP

CAPTRUST Financial Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75
Closed – – 5343
2022
Q1 		$0 Buy
+75
New – ﹤0.01% 5331

CAPTRUST Financial Advisors's SGYP Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2022, closing a stake of 75 shares.

CAPTRUST Financial Advisors first reported a position in SGYP in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 1 fund tracked by Wall St. Rank holds SGYP as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 75 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2022.
  • CAPTRUST Financial Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.